Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 66.13B | 69.54B | 67.94B | 60.54B | 54.95B | 44.81B |
Gross Profit | 20.68B | 21.93B | 21.35B | 17.60B | 15.68B | 12.32B |
EBITDA | 8.94B | 11.40B | 9.46B | 6.98B | 5.88B | 3.31B |
Net Income | 5.75B | 6.05B | 5.41B | 3.41B | 2.51B | 865.17M |
Balance Sheet | ||||||
Total Assets | 74.88B | 74.41B | 72.37B | 62.86B | 55.58B | 50.82B |
Cash, Cash Equivalents and Short-Term Investments | 8.22B | 10.12B | 7.86B | 7.41B | 7.21B | 8.07B |
Total Debt | 15.54B | 14.62B | 14.88B | 15.77B | 12.41B | 13.04B |
Total Liabilities | 31.32B | 29.75B | 31.79B | 29.55B | 26.47B | 25.16B |
Stockholders Equity | 42.82B | 43.78B | 39.77B | 32.51B | 28.34B | 24.92B |
Cash Flow | ||||||
Free Cash Flow | 318.13M | 3.48B | 3.65B | 310.31M | 575.51M | 839.38M |
Operating Cash Flow | 878.85M | 6.10B | 6.24B | 2.22B | 2.81B | 2.33B |
Investing Cash Flow | -308.16M | -351.28M | -2.04B | -2.00B | -2.30B | -1.53B |
Financing Cash Flow | -540.05M | -3.50B | -3.42B | -261.17M | -1.55B | 545.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥20.74B | 10.45 | 3.67% | 6.94% | 13.25% | ||
79 Outperform | ¥34.87B | 9.85 | 3.54% | 5.98% | 11.06% | ||
78 Outperform | ¥13.79B | 9.64 | 6.98% | 9.08% | 53.81% | ||
78 Outperform | ¥37.96B | 6.29 | 2.21% | 2.37% | 11.78% | ||
77 Outperform | ¥37.14B | 13.78 | 2.71% | 5.47% | 15.88% | ||
76 Outperform | ¥14.30B | 13.24 | 3.75% | 0.16% | 5.68% | ||
63 Neutral | $33.22B | 5.99 | -11.76% | 1.91% | 5.54% | -19.87% |